Health Care & Life Sciences » Biotechnology | Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc. | Mutual Funds

Mutual Funds that own Accelerate Diagnostics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
1,160,000
2.14%
865,000
1.97%
11/30/2017
Vanguard Total Stock Market Index Fund
667,628
1.23%
0
0%
07/31/2018
iShares Russell 2000 ETF
530,671
0.98%
-282
0.03%
09/06/2018
Buffalo Discovery Fund
428,625
0.79%
110,960
0.51%
03/31/2018
Nuveen Mid Cap Growth Opportunities Fund
426,999
0.79%
-3,746
1.38%
07/31/2018
Vanguard Extended Market Index Fund
353,128
0.65%
0
0.01%
07/31/2018
CS Investment Funds 2 - (Lux) Global Security Equity Fund
276,000
0.51%
276,000
0.75%
11/30/2017
iShares Russell 2000 Growth ETF
262,035
0.48%
0
0.06%
09/06/2018
Meridian Small Cap Growth Fund
259,324
0.48%
0
0.39%
03/31/2018
HBM BioVentures Ltd.
250,000
0.46%
250,000
0.42%
12/31/2017

About Accelerate Diagnostics

View Profile
Address
3950 South Country Club Road
Tucson Arizona 85714
United States
Employees -
Website http://acceleratediagnostics.com
Updated 07/08/2019
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.